On December 19, 2016, Novo Nordisk announced that the FDA ap | Figure 1

PedroPharmacist

Pharmacist

On December 19, 2016, Novo Nordisk announced that the FDA approved an expanded indication for Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL), once-daily, long-acting basal insulin, to be used in children and adolescents with diabetes. Trial, first approved by the FDA in September 2015, is now indicated to improve glycemic control in patients with type 1 and type 2 diabetes from the age of one through adulthood, making it the only basal insulin approved for both type 1 and type 2 diabetes in patients as young as 1 year old. Tresiba® is a long-acting insulin that is released over time, has a 25-hour half-life and has a consistently flat and stable profile at steady state.

Todd Hobbs, MD, US Chief Medical Officer, Novo Nordisk said that "we are seeing a rise in the number of children and adolescents with diabetes in the US, especially those with type 2, and are proud to support these patients by offering new and effective treatment options." The great challenge is children with type 1 diabetes and their parents to manage blood sugar levels and keep up with multiple injections throughout an already busy day. With this approval, they now have another option of a long-acting insulin that is dosed once daily.

Similar cases

56 y/o female rushed to the ER due to loss of consciousness, patient has type 2 DM insulin-requiring. You don't get to see this in a radiograph on a daily basis.

Update on Diabetic with Hypothyroid Here are the child's growth charts (weight on top & Body Mass index on bottom). The sharp drop occurred in under 2 months. Her insulin and thyroid antibodies are on the second slide. Remember her original labs were: HgbA1c >14; Glucose 339; Insulin 7.8. Currently doing well on insulin therapy. Endocrinologist is now controlling medications.

The patient complains of pain and heaviness in her right leg. She reports that her leg is swollen and that transparent liquid is coming out of her leg. She used Amoxicillin with clavulanate for five days, but there was no improvement. On clinical examination, the leg has edema, erythema and increased temperature. Peripheral venous insufficiency is noted. The patient is 62 years old. She has high blood pressure and type 2 diabetes mellitus. She is using Losartan and Insulin NPH. What is the diagnosis? And the treatment?

T2DM patient with tenia unguium .. Has well controlled diabetes now and planning for Terbenefine 250 once daily for 3 months .. Any suggestions regarding length of treatment?

Trending now

A 52-year-old man presented with a 20-minute history of chest pain radiating to the left shoulder and neck, associated with dyspnea and diaphoresis. He had a history of hypertension, long-term smoking, and a sedentary lifestyle. On physical examination, bibasilar crackles were noted on lung auscultation. An electrocardiogram (ECG) was performed in the primary care setting, and the patient was promptly referred to the emergency department.

A 28-year-old woman presented with a 3-day history of intense pruritus over the lower back. She reported no recent travel or exposure to new environments. She cares for a small kennel with approximately eight dogs rescued from the streets. Physical examination revealed multiple small vesicles, some clustered and others scattered, predominantly involving the lumbar region and the left gluteal area.

A 4-month-old male infant presented with skin lesions localized to the chin for the past 3 days. Physical examination revealed multiple small pustules with surrounding inflammatory signs on the chin, along with a few scattered papules on the chest.

Patient in late teens presenting after a collapse, no chest pain, no previous cardiac history, no history of sudden death in family, are there any features in this ekg that would warrant further work-up or is this just a pediatric ekg?